LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq:SLP), a leading provider of software for pharmaceutical discovery and development, today provided an update on the company’s operations and financial status in response to numerous investor requests in light of the current stock price.
